UNSPSC 51263704: Adaprolol maleate

This classification denotes a beta-adrenergic blocking agent with the molecular formula C26H39NO4.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2I8RV6WL9A, chemically known as benzeneacetic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, 2-tricyclo(3.3.1.1(sup 3,7))dec-1-ylethyl ester, (+-)-, (z)-2-butenedioate (1:1) (salt) but more generally known as adaprolol maleate, which bears US NIH Compound Identifier 6435805. Most nations, for tariff and trade purposes, schedule adaprolol maleate under HS 29221980 and SITC 51461.

As of Q4 2014, ADAPROLOL MALEATE remains US FDA's Preferred Term for this commodity. Adaprolol maleate bears US NLM identifiers UMLS ID C0645353 and NCI Concept Code C79960. SMILES: CC(C)NCC(COC1CCC(CC1)CC(=O)OCCC23CC4CC(C2)CC(C4)C3)O.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51263704 Adaprolol maleate is a Commodity code that nominally covers a specific pharmaceutical product, but recent state and local solicitations tagged with this code show minimal alignment with its stated scope. The one recent opportunity in the dataset—Seminole County, Florida's IFB60459723LAS—sought to procure naloxone (an opioid antagonist) and safe drug deactivation systems for community health initiatives, not adaprolol maleate (a beta-blocker used in cardiovascular treatment). The mismatch suggests either miscoding in the county's procurement system or a data-entry error rather than genuine activity in the adaprolol maleate category. State and local buyers using this code appear limited to health departments and county public health agencies when activity does occur, though the single recent opportunity provides insufficient evidence of a sustained procurement pattern.

Seminole County, Florida represents the only documented recent buyer under this code. The county issued an IFB on June 30, 2026, with a response deadline of July 26, 2023, seeking quarterly deliveries of 1,900 units of naloxone and 800 safe drug deactivation systems annually to its Community Health Building in Sanford, Florida. The contract carried an initial two-year term with an optional one-year renewal, required E-Verify compliance and drug-free workplace certification, and included potential FEMA funding with associated federal compliance obligations. No other state or local opportunities tagged to this code appear in recent records, indicating either dormant or severely limited procurement activity under the adaprolol maleate classification.